Literature DB >> 8745141

Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II.

J Frystyk1, B Dinesen, H Orskov.   

Abstract

We present sensitive non-competitive time-resolved immunofluorometric assays (TR-IFMAs) for IGF-I and IGF-II based on monoclonal antibodies. Assays were performed in microtest-plate wells: the first antibodies were immobilized on the solid matrix, the second labelled with the chelate derivative of Europium (Eu3+). The obtained specificities and sensitivities were high: IGF-I and IGF-II cross-reactivity in heterologous assay was below 0.0002%. The detection limits were 0.0025 micrograms/l and 0.010 micrograms/l for the IGF-I and IGF-II assay, respectively. The operating range included upwards: 2.5 micrograms/l (IGF-I) and 10.0 micrograms/l (IGF-II). This implies that all clinically relevant serum concentrations could be measured in one final dilution (1:1066 for IGF-I and 1:2132 for IGF-II) after acid ethanol extraction. The high sample dilution with buffer made further neutralization or evaporation of serum acid ethanol extracts unnecessary. Interassay variation of the assays was below 10%.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8745141

Source DB:  PubMed          Journal:  Growth Regul        ISSN: 0956-523X


  22 in total

1.  Biochemical assessment of disease control in acromegaly: reappraisal of the glucose suppression test in somatostatin analogue (SA) treated patients.

Authors:  Mai Christiansen Arlien-Søborg; Christian Trolle; Elin Alvarson; Amanda Bæk; Jakob Dal; Jens Otto Lunde Jørgensen
Journal:  Endocrine       Date:  2017-03-04       Impact factor: 3.633

2.  Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone.

Authors:  A Bojesen; N Birkebæk; K Kristensen; L Heickendorff; L Mosekilde; J S Christiansen; C H Gravholt
Journal:  Osteoporos Int       Date:  2010-07-24       Impact factor: 4.507

3.  Interferon-β treatment associated with a biochemical profile suggestive of acromegaly. A case report of a patient treated for multiple sclerosis.

Authors:  Mikkel Andreassen; Jan Frystyk; Karen K Miller; Lars Ø Kristensen
Journal:  Scand J Clin Lab Invest       Date:  2010-09-27       Impact factor: 1.713

4.  Testosterone and estradiol regulate free insulin-like growth factor I (IGF-I), IGF binding protein 1 (IGFBP-1), and dimeric IGF-I/IGFBP-1 concentrations.

Authors:  Johannes D Veldhuis; Jan Frystyk; Ali Iranmanesh; Hans Ørskov
Journal:  J Clin Endocrinol Metab       Date:  2005-02-15       Impact factor: 5.958

5.  Coordinated collagen and muscle protein synthesis in human patella tendon and quadriceps muscle after exercise.

Authors:  Benjamin F Miller; Jens L Olesen; Mette Hansen; Simon Døssing; Regina M Crameri; Rasmus J Welling; Henning Langberg; Allan Flyvbjerg; Michael Kjaer; John A Babraj; Kenneth Smith; Michael J Rennie
Journal:  J Physiol       Date:  2005-07-07       Impact factor: 5.182

6.  No effect of growth hormone administration on substrate oxidation during exercise in young, lean men.

Authors:  Mette Hansen; Rikke Morthorst; Benny Larsson; Rolf Dall; Allan Flyvbjerg; Michael Højby Rasmussen; Hans Orskov; Michael Kjaer; Kai Henrik Wiborg Lange
Journal:  J Physiol       Date:  2005-07-07       Impact factor: 5.182

Review 7.  Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study.

Authors:  Rasmus Sode-Carlsen; Stense Farholt; Kai Fr Rabben; Jens Bollerslev; Thomas Schreiner; Anne Grethe Jurik; Jens Sandahl Christiansen; Charlotte Höybye
Journal:  Endocrine       Date:  2011-11-12       Impact factor: 3.633

8.  Ethinyl oestradiol administration in women suppresses synthesis of collagen in tendon in response to exercise.

Authors:  Mette Hansen; Satu O Koskinen; Susanne G Petersen; Simon Doessing; Jan Frystyk; Allan Flyvbjerg; Eva Westh; S Peter Magnusson; Michael Kjaer; Henning Langberg
Journal:  J Physiol       Date:  2008-04-17       Impact factor: 5.182

9.  Short-term, low-dose GH therapy improves insulin sensitivity without modifying cortisol metabolism and ectopic fat accumulation in adults with GH deficiency.

Authors:  Kevin C J Yuen; Charles T Roberts; Jan Frystyk; William D Rooney; James R Pollaro; Bethany J Klopfenstein; Jonathan Q Purnell
Journal:  J Clin Endocrinol Metab       Date:  2014-07-11       Impact factor: 5.958

10.  Effects of oral contraceptives on diurnal profiles of insulin, insulin-like growth factor binding protein-1, growth hormone and cortisol in endurance athletes with menstrual disturbance.

Authors:  A Rickenlund; M Thorén; A Nybacka; J Frystyk; A Lindén Hirschberg
Journal:  Hum Reprod       Date:  2009-10-19       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.